United Therapeutics | UTHR - Marktkapitalisierung

Aktienkurs
533.37
Täglich Wechseln
-2.75 -0.51%
Monatlich
10.56%
Jährlich
65.16%
Q1 Prognose
519.93




Marktkapitalisierung Veränderung Datum
Amarin USD 341M 4M 2025-09
Ardelyx USD 1.33B 390M 2025-09
Baxter International USD 9.82B 1.87B 2025-12
Bayer EUR 36.89B 535.42M 2026-03
BioCryst Pharmaceuticals USD 1.7B 40M 2026-03
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Emergent BioSolutions USD 125M 51M 2023-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
J&J USD 500.24B 67.44B 2025-12
Lexicon Pharmaceuticals USD 416M 2M 2026-03
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Teva Pharmaceutical Industries USD 36.42B 14.06B 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12